These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 18000234)

  • 1. Evaluation of matrix metalloproteinase 2 expression in cervical carcinogenesis using tissue array and integrated optical density for immunoreactivity.
    Tee YT; Han CP; Ko JL; Chen GD; Yang SF; Chen SC; Tsai HJ; Lin LY; Wang PH
    Reprod Sci; 2007 Oct; 14(7):719-26. PubMed ID: 18000234
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A significant elevation of plasma level of matrix metalloproteinase-9 in patients with high-grade intraepithelial neoplasia and early squamous cell carcinoma of the uterine cervix.
    Yang SF; Wang PH; Lin LY; Ko JL; Chen GD; Yang JS; Lee HS; Hsieh YS
    Reprod Sci; 2007 Oct; 14(7):710-8. PubMed ID: 18000233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of matrix metalloproteinase-9 in squamous cell carcinoma of the uterine cervix-clinicopathologic study using immunohistochemistry and mRNA in situ hybridization.
    Davidson B; Goldberg I; Kopolovic J; Lerner-Geva L; Gotlieb WH; Weis B; Ben-Baruch G; Reich R
    Gynecol Oncol; 1999 Mar; 72(3):380-6. PubMed ID: 10053110
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MMP-1 and MMP-2 in the cervix uteri in different steps of malignant transformation--an immunohistochemical study.
    Brummer O; Böhmer G; Hollwitz B; Flemming P; Petry KU; Kühnle H
    Gynecol Oncol; 2002 Feb; 84(2):222-7. PubMed ID: 11812078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Expression of matrix metalloproteinase-2, 9 and their inhibitor-TIMP 1,2 in human squamous cell carcinoma of uterine cervix].
    Zhou CY; Yao JF; Chen XD
    Ai Zheng; 2002 Jul; 21(7):735-9. PubMed ID: 12479097
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Matrix metalloproteinase-2 (MMP-2) and its tissue inhibitor (TIMP-2) are prognostic factors in cervical cancer, related to invasive disease but not to high-risk human papillomavirus (HPV) or virus persistence after treatment of CIN.
    Branca M; Ciotti M; Giorgi C; Santini D; Di Bonito L; Costa S; Benedetto A; Bonifacio D; Di Bonito P; Paba P; Accardi L; Syrjänen S; Favalli C; Syrjänen K;
    Anticancer Res; 2006; 26(2B):1543-56. PubMed ID: 16619570
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Matrix metalloproteinase 2 immunoreactive protein appears early in cervical epithelial dedifferentiation.
    Talvensaari A; Apaja-Sarkkinen M; Höyhtyä M; Westerlund A; Puistola U; Turpeenniemi T
    Gynecol Oncol; 1999 Mar; 72(3):306-11. PubMed ID: 10053100
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Concurrent high expression of human telomerase reverse transcriptase and human nonmetastatic clone 23 in high-grade squamous intraepithelial neoplasia and squamous cell carcinoma of uterine cervix.
    Hsu CG; Wang PH; Ko JL; Chen GD; Chang H; Yang SF; Chen SC; Lin LY
    Int J Gynecol Cancer; 2007; 17(4):851-7. PubMed ID: 17359290
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SIRT1 overexpression in cervical squamous intraepithelial lesions and invasive squamous cell carcinoma.
    Velez-Perez A; Wang XI; Li M; Zhang S
    Hum Pathol; 2017 Jan; 59():102-107. PubMed ID: 27720890
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of membrane type 1 matrix metalloproteinase is associated with cervical carcinoma progression and invasion.
    Zhai Y; Hotary KB; Nan B; Bosch FX; Muñoz N; Weiss SJ; Cho KR
    Cancer Res; 2005 Aug; 65(15):6543-50. PubMed ID: 16061633
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of matrix metalloproteinase-2 in preinvasive and invasive carcinoma of the uterine cervix.
    Nasr M; Ayyad SB; El-Lamie IK; Mikhail MY
    Eur J Gynaecol Oncol; 2005; 26(2):199-202. PubMed ID: 15857029
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased expression of DNA methyltransferase 1 (DNMT1) protein in uterine cervix squamous cell carcinoma and its precursor lesion.
    Sawada M; Kanai Y; Arai E; Ushijima S; Ojima H; Hirohashi S
    Cancer Lett; 2007 Jun; 251(2):211-9. PubMed ID: 17196739
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Laminin-5 gamma2 chain and matrix metalloproteinase-2 expression in the neoplastic changes of uterine cervical squamous epithelium.
    Malina R; Motoyama S; Hamana S; Maruo T
    Kobe J Med Sci; 2004; 50(3-4):123-30. PubMed ID: 15925946
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early acquisition of gelatinolytic activity in carcinogenesis of the uterine cervix.
    Minami R; Tsunoda H; Iijima T; Yoshikawa H; Nemori R; Noguchi M
    Mod Pathol; 2003 Nov; 16(11):1164-70. PubMed ID: 14614057
    [TBL] [Abstract][Full Text] [Related]  

  • 15. nm23-H1 protein immunoreactivity in intraepithelial neoplasia and invasive squamous cell carcinoma of the uterine cervix.
    Lee CS; Gad J
    Pathol Int; 1998 Oct; 48(10):806-11. PubMed ID: 9788265
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative study of MMP-2 (matrix metalloproteinase 2) immune expression in normal uterine cervix, intraepithelial neoplasias, and squamous cells cervical carcinoma.
    Gaiotto MA; Focchi J; Ribalta JL; Stávale JN; Baracat EC; Lima GR; Guerreiro da Silva ID
    Am J Obstet Gynecol; 2004 May; 190(5):1278-82. PubMed ID: 15167830
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microinvasive cervical carcinoma and cervical intraepithelial neoplasia: biologic significance and clinical implications of 72-kDa metalloproteinase immunostaining.
    Garzetti GG; Ciavattini A; Lucarini G; Goteri G; De Nictolis M; Biagini G
    Gynecol Oncol; 1996 May; 61(2):197-203. PubMed ID: 8626132
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of MMP-2, MMP-9, and urokinase-type plasminogen activator in cervical intraepithelial neoplasia.
    No JH; Jo H; Kim SH; Park IA; Kang D; Lee CH; Han SS; Kim JW; Park NH; Kang SB; Song YS
    Ann N Y Acad Sci; 2009 Aug; 1171():100-4. PubMed ID: 19723042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Key enzymes of degradation and angiogenesis as a factors of tumor progression in squamous cell carcinoma of the cervix].
    Solov'eva NI; Timoshenko OS; Kugaevskaia EV; Andreeva IuIu; Zavalishina LE
    Bioorg Khim; 2014; 40(6):743-51. PubMed ID: 25895371
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Altered expression of cellular membrane molecules of HLA-DR, HLA-G and CD99 in cervical intraepithelial neoplasias and invasive squamous cell carcinoma.
    Zhou JH; Ye F; Chen HZ; Zhou CY; Lu WG; Xie X
    Life Sci; 2006 Apr; 78(22):2643-9. PubMed ID: 16434060
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.